Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of Reiki therapy on pain and anxiety in patients attending a day oncology and infusion services unit.
Birocco N, Guillame C, Storto S, Ritorto G, Catino C, Gir N, Balestra L, Tealdi G, Orecchia C, Vito GD, Giaretto L, Donadio M, Bertetto O, Schena M, Ciuffreda L. Birocco N, et al. Among authors: bertetto o. Am J Hosp Palliat Care. 2012 Jun;29(4):290-4. doi: 10.1177/1049909111420859. Epub 2011 Oct 13. Am J Hosp Palliat Care. 2012. PMID: 21998438
Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: phase II trial.
Buffoni L, Dongiovanni D, Barone C, Fissore C, Ottaviani D, Dongiovanni V, Grillo R, Salvadori A, Birocco N, Schena M, Bertetto O. Buffoni L, et al. Among authors: bertetto o. Lung Cancer. 2006 Dec;54(3):353-7. doi: 10.1016/j.lungcan.2006.08.013. Epub 2006 Oct 17. Lung Cancer. 2006. PMID: 17049672 Clinical Trial.
Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
Schena M, Barone C, Birocco N, Dongiovanni D, Numico G, Colantonio I, Bertetto O. Schena M, et al. Among authors: bertetto o. Cancer Chemother Pharmacol. 2005 Mar;55(3):271-6. doi: 10.1007/s00280-004-0875-1. Epub 2004 Nov 16. Cancer Chemother Pharmacol. 2005. PMID: 15592837 Clinical Trial.
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
Barone C, Grillo R, Dongiovanni D, Birocco N, Rampino M, Redda MG, Garibaldi E, Munoz F, Pecorari G, Cavalot A, Garzinodemo P, Buffoni L, Ciuffreda L, Ricardi U, Cortesina G, Giordano C, Fasolis M, Berrone S, Bertetto O, Schena M. Barone C, et al. Among authors: bertetto o. Anticancer Res. 2008 Mar-Apr;28(2B):1285-91. Anticancer Res. 2008. PMID: 18505067 Free article. Clinical Trial.
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network.
Brizzi MP, Berruti A, Ferrero A, Milanesi E, Volante M, Castiglione F, Birocco N, Bombaci S, Perroni D, Ferretti B, Alabiso O, Ciuffreda L, Bertetto O, Papotti M, Dogliotti L. Brizzi MP, et al. Among authors: bertetto o. BMC Cancer. 2009 Nov 3;9:388. doi: 10.1186/1471-2407-9-388. BMC Cancer. 2009. PMID: 19886987 Free PMC article. Clinical Trial.
Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens.
Daniele L, Macrì L, Schena M, Dongiovanni D, Bonello L, Armando E, Ciuffreda L, Bertetto O, Bussolati G, Sapino A. Daniele L, et al. Among authors: bertetto o. Mol Cancer Ther. 2007 Apr;6(4):1223-9. doi: 10.1158/1535-7163.MCT-06-0719. Epub 2007 Apr 3. Mol Cancer Ther. 2007. PMID: 17406029
108 results